CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Enamel Pro +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01629290
NCT01629290N/ACompleted
CompareCT.gov

In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes

University of Michigan·interventional·Posted Jun 27, 2012·Updated May 22, 2017

In Brief

A clinical study evaluating Enamel Pro, Duraphat, and 2 other interventions for Dental Caries. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This study will be a cross-over single blinded clinical study to evaluate the in vitro fluoride release of three different brands of 5% NaF varnish. The goal of this study is to determine if different formulations of varnish lead to differing amounts of fluoride release. Despite their similar concentrations of NaF (5%), some in vitro data have suggested that they may differ in the amount of fluoride release. Determining fluoride release of these varnishes in vivo is important in assessing both the safety and efficacy of the product.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Caries
CountriesUnited States
CollaboratorsDelta Dental Fund of Michigan

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 27, 2012
Enrollment StartJun 1, 2012
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 14.0 years ago

Interventions

Enamel Prodevice

Varnish treatment containing 5% NaF

Duraphatdevice

Varnish treatment containing 5% NaF

Vanishdevice

Varnish treatment containing 5% NaF

Placebodevice

Bland varnish containing no NaF